期刊文献+

MT2受体介导褪黑素对小鼠前胃癌细胞的抑制作用 被引量:1

Inhibitory effect of melatonin on murine foregastric carcinoma cells via membrane receptors MT2
下载PDF
导出
摘要 目的探讨褪黑素(MLT)通过褪黑素膜受体MT2抑制小鼠前胃癌(MFC)细胞增殖及其与丝裂原活化蛋白激酶(MAPKs)、磷脂酰肌醇-3激酶(PI3K)-Akt信号通路的关系。方法应用siRNA技术沉默MT2表达,观察褪黑素对小鼠前胃癌细胞的抑制作用及ERK1/2、Akt的磷酸化的影响。结果 1.siRNA介导的MT2沉默能明显拮抗褪黑素对胃癌细胞增殖的抑制作用;2.沉默MT2可部分阻断褪黑素抑制ERK1/2、Akt磷酸化的作用。结论褪黑素可通过MT2受体抑制ERK1/2、Akt的磷酸化从而抑制胃癌细胞增殖。 Objective To investigate the inhibitory effect of melatonin on the proliferation activity of murine foregastic carcinomac ( MFC) cells via melatonin membrane receptors MT 2 and its relationship with the signaling pathways of mitogen-activated protein kinases ( MAPKs), phosphatidylinositol 3-kinase ( PI3K)-Akt.Methods Using siRNA technology to silence MT2 expression, we examined the ability of melatonin to inhibit the proliferation activity of MFC cells and its influence on the phosphorylation of ERK 1/2 and Akt.Results We found two interesting effects of SiRNA-mediated silencing of MT2 expression.Firstly, it significantly antagonized the inhibitory effect of melatonin on the proliferation activity of MFC cells .Secondly , it partially blocked the inhibitory effect of melatonin on the phosphorylation of ERK 1/2 and Akt.Conclusion Our results suggest that melatonin can inhibit the phosphorylation of ERK 1/2 and Akt via MT2 receptors , thereby inhibiting the proliferation of gastric cancer cells .
出处 《解剖学报》 CAS CSCD 北大核心 2014年第3期344-349,共6页 Acta Anatomica Sinica
基金 国家自然科学基金资助项目(30971541) 福建省科技厅重点资助项目(2012Y0033) 福建省自然科学基金资助项目(2012J01411) 莆田市科技计划资助项[2012S11(2)]
关键词 褪黑素 小鼠前胃癌细胞 褪黑素膜受体MT2 AKT ERK1 2 实时定量聚合酶链反应 小鼠 Melatonin Murine foregastic carcinoma cell Melatonin membrane receptor MT2 Akt ERK1/2 Real-time PCR Mouse
  • 相关文献

参考文献18

  • 1Crew KD, Neugut AI. Epidemiulogy of gastric cancer[J].World J Gastroenterol, 2006, 12 (3) : 354-362. 被引量:1
  • 2Sánchez-Hidalgo M, Lee M, de la Lastra CA, et al. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines [ J ]. J Pineal Res, 2012, 53(4) : 366-373. 被引量:1
  • 3Tam CW, Shin SY. Functional interplay between melatonin receptor-medlated antiproliferative signaling and androgen receptorsignaling in human prostate epithelial cells: potential implleations for therapeutic strategies against prostate cancer[ J ]. J Pineal Res, 2011, 51 (3):297-312. 被引量:1
  • 4Konturek PC, Konturek S J, Burnat G, et al. Dynamic physiological and molecular changes in gastric ulcer healing aehieved by melatonin and its precursor L-tryptophan in rats[ J ].J Pineal Res, 2008, 45 (2) : 180-190. 被引量:1
  • 5Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy [J]. CurrTop Med Chem, 2002, 2(2): 113-132. 被引量:1
  • 6Xu L, Liu H, Zhang H, et al. Growth-inhibitory activity of melatoninon murine foregastric carcinom a cells in vitro and the underlying molecular mechanism[J].Anat Rec, 2013, 296:914-920. 被引量:1
  • 7刘卉,蒋继浩,徐丽,宫喜,周瑞祥.褪黑素体内外对小鼠前胃癌细胞的增殖抑制与凋亡诱导作用[J].解剖学报,2011,42(6):792-797. 被引量:6
  • 8Liu H, Xu L, Wei JE, et al. Role of CD4 + CD25 + regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth invivoand in vitro[J]. Anat Rec, 2011, 294(5) :781- 788. 被引量:1
  • 9Cutando A, Aneiros-Fernández J, Aneiros-Cachaza J, et al. Melatonin and cancer: current knowledge and its application to oral cavity tumours[J]. J Oral Pathol Med, 2011, 40(8) :593-597. 被引量:1
  • 10Kobayashi Y, Itoh MT, Kondo H, et al. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer[J]. JPinealRes, 2003, 35(2):71-74. 被引量:1

二级参考文献17

  • 1Hill S M, Frasch T, Xiang S, et al. Molecular mechanisms of melatonin anticancer effects [ J ]. Integr Cancer Ther, 2009, 8 (4) : 337-346. 被引量:1
  • 2Muc-Wierzgon M, Nowakowska-Zajdel E, Zubelewicz B, et al.Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer[ J]. Exp Clin Cancer Res, 2003, 22 (2) : 171-178. 被引量:1
  • 3Tu SP, Jiang XH, Lin MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer[J]. Cancer Res, 2003, 63(5): 7724-7732. 被引量:1
  • 4Moechegiani E, Perissin L, Santarelli L, et al. Melatonin administration in tumor-beating mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2 [ J ]. Int J Immunopharmacol, 1999, 21 ( 1 ) : 27-46. 被引量:1
  • 5Srinivasan V, Spence DW, Pandi-Perumal SR, et al. Therapeutic actions of melatonin in cancer: possible mechanisms [ J ]. Integr Cancer Ther, 2008, 7(3) : 189-203. 被引量:1
  • 6Saez MC, Barriga C, Garcia JJ, survival time of animals with neuroendocrine stabilization [ J ]. (3) : 15-20. et al. Melatonin increases the untreated mammary tumours: Mol Cell Biochem, 2005, 278. 被引量:1
  • 7Sainz RM, Mayo JC, Tan D , et al. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via receptor and PKA independentmechanism[J]. Prostate, 2005, 63 (3) : 29-43. 被引量:1
  • 8Alessandra C, Sara P, Fabrizio DA, et al. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells[J]. Pineal Res, 2009, 46(3) : 172-180. 被引量:1
  • 9Wenzel U, Nickel A, Daniel H. Melatonin potentiates flavoneinduced apoptosis in human colon cancer cells by increasing thelevel of glycolytic end products[J]. Int J Cancer, 2005, 116(3) : 236-242. 被引量:1
  • 10Yang QH, Xu JN, Xu RK, et al. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro[J]. Pineal Res, 2007, 42(4) :172-179. 被引量:1

共引文献5

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部